Cyber Cao, M.S., is a Managing Director based in Shanghai. Cyber joined Vivo with extensive healthcare experience. After joining Vivo in 2011, Cyber participated most of the Vivo Fund VII investment in China and currently serves on the board of SMC and Gengmei APP.
Prior to joining Vivo, Cyber was the leader of Nycomed North Asia strategy and business development. He helped Nycomed refurbish its China business and played an integral role in its acquisition of Techpool, a leading Chinese pharmaceutical player. Prior to Nycomed, Cyber was at McKinsey & Company where he worked with both multi-national and local pharmaceutical companies on corporate strategy. Mr. Cao received his M.S. in Pharmacy Administration and a B.S. in Pharmaceutics from Peking University.